KPV specifications and research profile
Specifications summary
| Designation | C-terminal alpha-MSH tripeptide fragment |
|---|---|
| Also known as | KPV; Lys-Pro-Val |
| Sequence / composition | Lys-Pro-Val |
| Strength | 10mg × 10 vials |
| Presentation | 10-vial case |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
KPV is the three-residue Lys-Pro-Val sequence corresponding to the C-terminal region of alpha-melanocyte-stimulating hormone. Its small size makes it useful in transporter and fragment-comparison studies.
Published epithelial- and immune-cell experiments measured PepT1-dependent uptake together with NF-kappaB, MAP-kinase and cytokine readouts. Results are model- and stimulus-specific.
Applications in research
- PepT1 uptake and competition assays
- NF-kappaB and MAP-kinase signalling models
- Short-fragment structure-activity comparisons
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Research references
KPV research record
Clear product, batch, storage, dispatch and document information for this 10-vial case.
Research context
The Lys-Pro-Val tripeptide is studied in PepT1 transport, NF-kappaB and MAP-kinase signalling models using epithelial and immune cells.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.